As a United States national paramedic student, can you describe Lyme disease—including normal anatomy and pathological changes, relevant history and demographics, key early and late signs and symptoms, assessment findings for paramedics, emergency medical services management from the initial call through transport and appropriate receiving facility, chronic treatment medications and their mechanisms, and complications arising from delayed therapy?

Lyme Disease: Comprehensive Guide for US National Paramedic Practice

Normal Anatomy and Pathophysiology

Lyme disease is a tick-borne bacterial infection caused by Borrelia burgdorferi spirochete, transmitted through bites from Ixodes scapularis (deer tick) in the northeastern and north-central US, and Ixodes pacificus on the Pacific coast 1.

Normal vs. Pathological States

Normal state: The skin, nervous system, cardiovascular system, and musculoskeletal system function without spirochete invasion. The immune system maintains tissue integrity without inflammatory response to bacterial antigens.

Pathological changes: When the spirochete enters dermal tissue through tick saliva, it triggers localized inflammation at the bite site. The bacteria's outer surface lipoproteins provoke immune responses that cause tissue damage 2. The spirochete can disseminate hematogenously to multiple organ systems:

• Skin: Inflammatory infiltrate causes erythema migrans (EM) - expanding erythematous lesion at bite site
• Nervous system: Meningeal inflammation, cranial nerve involvement (especially CN VII), radiculoneuritis
• Cardiovascular: Myocardial inflammation causing conduction abnormalities, particularly AV blocks
• Musculoskeletal: Synovial inflammation leading to joint effusions, particularly in large joints like knees

Demographics and Epidemiology

The highest-risk demographics are individuals living in or visiting endemic areas (New England, mid-Atlantic states, Minnesota, Wisconsin) during May-September, particularly those with outdoor exposure in wooded or grassy areas 1.

Why These Demographics Matter:

• Geographic concentration: Tick infection rates reach ≥20% in endemic regions 1
• Seasonal pattern: Nymphal ticks (primary vectors) are most active late spring through summer
• Occupational/recreational exposure: Hikers, campers, outdoor workers, children playing outdoors
• Age distribution: All ages affected, but outdoor activity patterns influence exposure
• Tick attachment time: Transmission typically requires 36-48 hours of tick attachment

Clinical Presentation: Early vs. Late Findings

Early Localized Stage (3-30 days post-bite, typically 7-14 days)

Erythema migrans is the hallmark and most common manifestation, occurring in approximately 80% of cases 1, 3:

Skin findings you'll assess:

• Expanding erythematous lesion ≥5 cm diameter (critical diagnostic threshold)
• Round or oval shape with central clearing ("bull's-eye") or homogeneous redness
• Located at tick bite site (axilla, groin, popliteal fossa, abdomen, waist common)
• Warm to touch but NOT painful
• May have mild itching but NOT intensely pruritic
• Expands over days to weeks, can reach 20 cm
• May have central vesicle/pustule (~5% of cases)

Systemic symptoms (viral-like illness):

• Fatigue, malaise
• Headache
• Fever (~20% of patients)
• Myalgias, arthralgias
• Regional lymphadenopathy
• Loss of appetite

Critical distinction: If skin lesion appears within 48 hours of tick removal and is <5 cm, suspect hypersensitivity reaction, NOT Lyme disease 1.

Early Disseminated Stage (Days to weeks after infection)

Multiple erythema migrans lesions indicate hematogenous dissemination and represent more serious disease 1, 3:

Neurological findings (occurs in 6-15% of cases):

• Facial nerve palsy (unilateral or bilateral CN VII palsy)
• Meningitis symptoms: severe headache, neck stiffness, photophobia
• Radiculoneuritis: shooting pains, sensory changes
• Bannwarth syndrome: meningitis + cranial neuropathy + radiculopathy triad

Cardiac findings (4-8% of cases):

• Lyme carditis - THIS IS YOUR EMERGENCY:
  • Dyspnea, chest pain
  • Palpitations, lightheadedness
  • Syncope or presyncope (critical red flag)
  • Signs of heart failure: edema, orthopnea
  • Bradycardia from AV blocks (1st, 2nd, or 3rd degree)

Late Disseminated Stage (Months to years after infection)

Lyme arthritis (45-60% of untreated patients):

• Intermittent or persistent monoarticular or oligoarticular arthritis
• Large joints affected, especially knees
• Joint swelling, warmth, effusion
• May be first manifestation without prior early symptoms

Late neurological:

• Subtle encephalopathy: memory problems, cognitive difficulties
• Peripheral neuropathy: numbness, tingling in extremities
• Chronic radiculopathy

Chronic skin (rare in US, more common in Europe):

• Acrodermatitis chronica atrophicans: atrophic skin changes on extremities

Paramedic Scene Assessment and Transport Decisions

Initial Scene Size-Up and Primary Assessment

Your immediate priorities are identifying life-threatening cardiac complications and neurological emergencies:

1. ABCs with cardiac focus:

   • Assess for bradycardia (pulse <60 with symptoms)
   • Monitor for syncope/presyncope history
   • Check for respiratory distress

2. Rapid neurological screen:

   • Facial symmetry (CN VII palsy)
   • Neck stiffness (meningitis)
   • Altered mental status

3. Skin examination:

   • Look for expanding erythematous lesions ≥5 cm
   • Check for multiple lesions (disseminated disease)
   • Note location and characteristics

Pertinent History Questions

Ask specifically:

• "Have you been in wooded or grassy areas in the past month?"
• "Did you find or remove any ticks?"
• "When did this rash first appear? Is it getting bigger?"
• "Have you had fever, headache, or neck stiffness?"
• "Any chest pain, palpitations, or passing out?"
• "Any facial drooping or weakness?"
• "Any joint pain or swelling?"

Critical Assessment Findings Requiring Immediate Action

OBTAIN 12-LEAD ECG if patient reports:

• Dyspnea, chest pain, palpitations
• Lightheadedness, syncope, presyncope
• Any cardiac symptoms with EM rash or Lyme disease history 4

ECG findings indicating Lyme carditis:

• PR interval >300 milliseconds (CRITICAL - requires hospitalization)
• Any degree AV block (1st, 2nd, 3rd degree)
• Other arrhythmias
• ST-T wave changes suggesting myopericarditis

Transport Decisions

IMMEDIATE TRANSPORT TO EMERGENCY DEPARTMENT (preferably with cardiac capabilities) if:

• PR interval >300 ms on ECG
• Any symptomatic bradycardia or AV block
• Syncope or presyncope
• Signs of heart failure
• Severe headache with neck stiffness (meningitis)
• Bilateral facial palsy
• Altered mental status

These patients require hospital admission with continuous cardiac monitoring 4.

ROUTINE TRANSPORT TO EMERGENCY DEPARTMENT if:

• Erythema migrans present (needs antibiotic therapy)
• Multiple EM lesions (disseminated disease)
• Unilateral facial palsy
• Significant joint swelling
• Systemic symptoms with tick exposure history

ADVISE OUTPATIENT FOLLOW-UP (non-emergent) if:

• Small lesion <5 cm appearing within 48 hours of tick removal (likely hypersensitivity)
• Isolated arthralgias without objective findings
• Vague symptoms without EM or objective findings

Ongoing Assessment During Transport

Continuous monitoring:

• Cardiac monitor for rhythm changes (watch for progression of AV blocks)
• Vital signs every 5-10 minutes if cardiac involvement suspected
• Neurological status (GCS, facial symmetry, pupil response)
• Respiratory status if dyspnea present

Reassess:

• Chest pain characteristics
• Level of consciousness
• Perfusion status

EMS Treatment and Management

Prehospital Interventions

For suspected Lyme carditis with symptomatic bradycardia:

• Establish IV access
• Place on continuous cardiac monitor
• Prepare transcutaneous pacing pads (DO NOT pace unless symptomatic and unstable)
• Oxygen if hypoxic (SpO2 <94%)
• Position of comfort (usually semi-Fowler's for dyspnea)
• Rapid transport - temporary pacing may be needed, NOT permanent pacemaker 4

For neurological involvement:

• Protect airway if altered mental status
• Position to prevent aspiration if facial palsy present
• IV access for suspected meningitis
• Rapid transport

For isolated EM without complications:

• Supportive care
• Document rash characteristics (size, location, appearance)
• Photograph if possible per protocol
• Routine transport

CRITICAL PITFALL: Do NOT delay transport for extensive assessment if cardiac or neurological complications suspected. Time-sensitive conditions require hospital-based management.

Facility Selection

Transport to facilities with:

• Cardiac catheterization lab/cardiology services if Lyme carditis suspected (temporary pacing capability essential)
• Neurology consultation availability if CNS involvement
• Infectious disease consultation for complex cases
• Emergency department with laboratory capabilities for serologic testing

Avoid urgent care or clinics - these patients need hospital-based evaluation and potential admission 4.

Chronic Lyme Disease: Medications and Management

Most Lyme disease is NOT chronic - it's cured with appropriate antibiotic therapy 4, 1. However, you may encounter patients on treatment or with post-treatment symptoms.

Medications Patients May Be Taking

Oral antibiotics (most common):

1. Doxycycline 100 mg twice daily

   • First-line for most manifestations
   • Duration: 10 days (isolated EM), 14 days (multiple EM, early neuroborreliosis), 21 days (late neuroborreliosis), 28 days (Lyme arthritis) 5
   • Mechanism: Inhibits bacterial protein synthesis by binding 30S ribosomal subunit
   • What it does: Kills Borrelia burgdorferi spirochetes

2. Amoxicillin 500 mg three times daily

   • Alternative for pregnant women, children <8 years
   • Duration: Same as doxycycline based on manifestation 5
   • Mechanism: Inhibits bacterial cell wall synthesis
   • What it does: Bactericidal against spirochetes

3. Cefuroxime axetil 500 mg twice daily

   • Alternative oral cephalosporin
   • Mechanism: Inhibits cell wall synthesis
   • What it does: Kills spirochetes

IV antibiotics (for severe disease):

1. Ceftriaxone 2 g IV daily
   • Used for severe carditis, CNS involvement
   • Duration: 14-28 days depending on manifestation
   • Mechanism: Third-generation cephalosporin, inhibits cell wall synthesis
   • What it does: Penetrates CNS and cardiac tissue to eradicate spirochetes

Important: Patients should NOT be on prolonged or repeated antibiotic courses. Guidelines strongly recommend against extended antibiotic therapy beyond standard durations 4, 6.

Post-Treatment Lyme Disease Syndrome (PTLDS)

Approximately 10% of treated patients develop persistent symptoms:

• Fatigue, cognitive difficulties
• Musculoskeletal pain
• NOT responsive to additional antibiotics 2, 6
• Managed symptomatically (NSAIDs, physical therapy, supportive care)

If you encounter a patient on long-term antibiotics (>28 days), this is NOT guideline-concordant care 4.

Complications of Untreated or Delayed Treatment

Delayed diagnosis and treatment leads to progression through disease stages with increasing morbidity:

Cardiac Complications (Most Life-Threatening)

Lyme carditis develops in 4-8% of untreated patients 1:

• Complete heart block - can cause sudden cardiac death
• Myopericarditis - heart failure, cardiogenic shock
• Arrhythmias - ventricular tachycardia, sudden death
• Mechanism: Spirochete invasion of myocardium causes inflammatory damage to conduction system and myocytes
• Timeline: Typically weeks after initial infection
• Mortality risk: Rare but documented sudden cardiac deaths in young, previously healthy individuals

Why it happens: Untreated spirochetemia allows bacterial dissemination to cardiac tissue. The inflammatory response damages the AV node and surrounding conduction pathways.

Neurological Complications

Neuroborreliosis occurs in 11% of untreated patients 1:

Early (weeks to months):

• Meningitis - can cause severe headache, cognitive impairment
• Cranial neuropathies - facial palsy may become permanent if untreated
• Radiculoneuritis - severe pain, sensory/motor deficits
• Mechanism: Spirochete invasion of CNS and peripheral nerves triggers inflammatory response

Late (months to years):

• Encephalopathy - memory loss, cognitive decline, personality changes
• Peripheral neuropathy - chronic pain, numbness, weakness
• Encephalomyelitis - rare but severe CNS inflammation
• Mechanism: Chronic inflammation and possible persistent infection in nervous tissue

Why it happens: Spirochetes cross blood-brain barrier, triggering immune-mediated damage to neural tissue. Delayed treatment allows establishment of chronic infection.

Musculoskeletal Complications

Lyme arthritis develops in 45-60% of untreated patients 1, 6:

• Chronic monoarticular or oligoarticular arthritis
• Joint damage and erosion with prolonged inflammation
• Synovial hypertrophy requiring surgical synovectomy in refractory cases
• Mechanism: Spirochetes in synovial fluid trigger inflammatory arthritis; immune response causes cartilage and bone damage

Why it happens: Hematogenous dissemination seeds joints with bacteria. The immune response to bacterial antigens causes persistent inflammation even after bacterial clearance in some patients.

Dermatological Complications (More common in Europe)

Acrodermatitis chronica atrophicans:

• Chronic atrophic skin changes on extremities
• Irreversible tissue damage
• Associated with B. afzelii (European species)

Quality of Life Impact

Post-Treatment Lyme Disease Syndrome (PTLDS):

• Affects ~10% of treated patients 2
• Chronic fatigue, cognitive difficulties, pain
• Significantly impairs quality of life
• NOT improved by additional antibiotics 4, 6
• Mechanism unclear - possibly immune dysregulation or residual tissue damage

Why it happens: Unclear etiology. Theories include persistent immune activation, tissue damage from initial infection, or other post-infectious phenomena. NOT due to persistent active infection.

Prevention of Complications

Early recognition and treatment prevents progression:

• Treatment within first 3-30 days (EM stage) prevents disseminated disease in most cases 1
• 10-day course of doxycycline for isolated EM has excellent outcomes 5
• Delayed treatment (weeks to months) increases risk of cardiac, neurological, and arthritic complications

Critical timing: The window between EM appearance and dissemination is your opportunity to prevent serious complications. This is why paramedic recognition and appropriate transport for early treatment is crucial.

Common Pitfalls and How to Avoid Them

Pitfall 1: Dismissing small rashes as "spider bites" or allergic reactions

• Avoid by: Measuring all erythematous lesions; if ≥5 cm and expanding, suspect Lyme disease regardless of patient's tick bite recall

Pitfall 2: Missing cardiac involvement in patients with vague symptoms

• Avoid by: Obtaining 12-lead ECG on ANY patient with EM rash PLUS dyspnea, palpitations, lightheadedness, or syncope 4

Pitfall 3: Assuming facial palsy is always stroke

• Avoid by: Checking for forehead involvement (present in Lyme, absent in stroke) and asking about tick exposure, rashes, outdoor activities

Pitfall 4: Transporting cardiac patients to facilities without temporary pacing capability

• Avoid by: Recognizing that Lyme carditis requires TEMPORARY pacing, not permanent pacemaker 4; choose appropriate receiving facility

Pitfall 5: Confusing tick bite hypersensitivity with EM

• Avoid by: Timing (hypersensitivity <48 hours, EM >3 days), size (hypersensitivity <5 cm, EM ≥5 cm), and progression (hypersensitivity resolves, EM expands) 1

Pitfall 6: Delaying transport for extensive history in unstable patients

• Avoid by: Prioritizing ABCs and cardiac monitoring; obtain history en route for time-sensitive conditions